000			04873cam a2200445M 4500
999			_c96404 _d96404
001			96404
003			ES-MaUEC
005			20230102112752.0
006			m o d
007			cr |n|||||||||
008			170810s2017 sz o 000 0 eng d
020			_a3319609076 _q(electronic bk.)
020			_a9783319609072 _q(electronic bk.)
020			_z3319609068
020			_z9783319609065
040			_aYDX _cYDX _dN$T _dEBLCP _dGW5XE _dN$T _dOCLCF _dUAB _dAZU _dUPM _dMERER _dOCLCQ _dESU _dIOG _dCOO _dJG0 _dES-MaUEC _bspa
050		4	_aQH603.E93 _b2017 EB
245	0	0	_aExtracellular matrix in tumor biology _cRolf A. Brekken, Dwayne Stupack, editors.
264		1	_aCham _bSpringer _c2017.
300			_a1 recurso en línea
336			_aTexto _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
347			_atext file _bPDF
490	0		_aBiology of extracellular matrix _x0887-3224
500			_aSpringerLink
505	0		_aPreface; Contents; Chapter 1: The Extracellular Matrix of Tumors: A Focus on Fibronectin and Fibulin-5; 1.1 The Function and Composition of the Extracellular Matrix; 1.2 The Role of the ECM in Tumor Development with Emphasis on FN; 1.3 Matricellular Proteins: Extracellular Modulators of the ECM; 1.4 Fibulin-5; 1.4.1 Fbln5 in Cell Adhesion/Migration; 1.4.2 Fbln5 in Proliferation/Survival; 1.4.3 Fbln5 in Angiogenesis; 1.4.4 Fbln5 in Tumor Progression; 1.5 Conclusion; References; Chapter 2: Internalization of Collagen: An Important Matrix Turnover Pathway in Cancer
505	8		_a2.1 Collagen Degradation in Cancer2.2 Extracellular Collagen Degradation; 2.3 Intracellular Collagen Degradation; 2.3.1 The Collagen Internalization Receptor uPARAP/Endo180; 2.3.2 The Collagen Internalization Receptor MR; 2.4 Intracellular Collagen Degradation In Vivo; 2.4.1 Imaging Collagen Internalization In Vivo; 2.4.2 Intracellular Collagen Degradation in Cancer; References; Chapter 3: Lumican, a Small Leucine-Rich Proteoglycan, and Its Biological Function in Tumor Progression; 3.1 Structure, Function, and Regulation of Lumican; 3.2 Lumican Implications in Cancer; 3.2.1 Breast Cancer
505	8		_a3.2.2 Colorectal Cancer3.2.3 Lung Cancer; 3.2.4 Pancreatic Cancer; 3.3 Drug Delivery in Cancer and Its Association with Lumican Expression; 3.3.1 Collagen Organization in Tumors; 3.3.2 VEGF and PDGF; 3.4 Summary; References; Chapter 4: Versican: Role in Cancer Tumorigenesis; 4.1 Introduction; 4.2 Source of Versican in Cancer; 4.3 The Role of Versican in Cancer; 4.4 The Regulation of Versican Expression in Cancer; 4.5 Versican as a Diagnostic and Prognostic Marker in Cancer; 4.6 Versican in LMS: Our Experience; 4.7 Conclusions; References
505	8		_a6.2.1 Transcription Factors Promoting Invasion6.2.2 Establishing the Invasive Cell Membrane; 6.2.3 AC Invadopodia and the Invasive Protrusion: Breaching and Clearing the BM; 6.3 Post AC Invasion: BM Sliding Further Opens the Breach; 6.4 AC Invasion and SPARC: A Model for the Tumor Microenvironment; 6.5 Summary and Perspective; References
505	8		_aChapter 5: Engineering Advanced Models of the Glioblastoma Microenvironment Using Biomaterials5.1 Introduction; 5.2 The Role of the Microenvironment in GBM Malignancy; 5.2.1 ECM; 5.3 Engineering Advanced Models of the GBM Microenvironment; 5.3.1 Traditional Culture Systems; 5.3.2 Polymer-Based 3D Matrices; 5.3.3 Microfabricated Platforms; 5.3.4 Molecular Discovery and Screening; 5.4 Future Directions; 5.5 Conclusions; References; Chapter 6: Breaching and Opening Basement Membrane Barriers: The Anchor Cell Leads the Way; 6.1 Introduction; 6.2 Breaching the BM De Novo: AC Invasion
520	3		_aThis volume provides an overview on the influence of Extracellular Matrix (ECM) on tumor progression. It covers topics such as signaling induced by structural ECM proteins including collagen and fibronectin, the control of ECM deposition and the turnover in tumors. Also discussed are the migration of cells through basement membranes and the function of proteoglycans including lumican and veriscan in tumor progression. Biomaterial-based in-vitro models as well as C. elegans models of the tumor microenvironment are used to show how these models can lead to a greater understanding of the disease mechanisms that promote cancer progression. The book addresses researchers working on cancer biology or ECM, and oncologists alike.
988			_aEBOOK, asignarmaterias, EBSPRINGER_2017D
650		7	_aCitología _2embne _0(OCoLC)fst00918995 _9139477
700	1		_aBrekken, Rolf A.
700	1		_aStupack, Dwayne.
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=http://link.springer.com/10.1007/978-3-319-60907-2 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942			_2lcc _cLE
998			_b02/2018 _dz _e- _zSI